LMAT - LeMaitre Vascular, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
110,516
105,568
100,867
89,151
78,352
Cost of Revenue
34,264
31,629
30,170
26,215
24,186
Gross Profit
76,252
73,939
70,697
62,936
54,166
Operating Expenses
Research Development
8,880
8,197
6,636
6,141
5,479
Selling General and Administrative
46,814
45,007
42,958
40,459
36,790
Total Operating Expenses
55,694
53,204
49,594
46,600
43,013
Operating Income or Loss
20,558
20,735
21,103
16,336
11,153
Interest Expense
-
2
21
14
-
Total Other Income/Expenses Net
1,274
7,709
3
-94
271
Income Before Tax
22,582
28,444
21,106
16,242
11,424
Income Tax Expense
4,106
5,501
3,929
5,652
3,666
Income from Continuing Operations
18,476
22,943
17,177
10,590
7,758
Net Income
18,476
22,943
17,177
10,590
7,758
Net Income available to common shareholders
18,476
22,943
17,177
10,590
7,758
Reported EPS
Basic
-
1.18
0.91
0.57
0.44
Diluted
-
1.13
0.86
0.55
0.42
Weighted average shares outstanding
Basic
-
19,426
18,961
18,485
17,764
Diluted
-
20,242
20,033
19,241
18,316
EBITDA
-
20,735
21,103
16,336
11,153